Metallo-beta-lactamase type 2

BE0002694ProteinChryseobacterium meningosepticumblaB1

Confers resistance to the different beta-lactams antibiotics (penicillin, cephalosporin and carbapenem) via the hydrolysis of the beta-lactam ring. It is acted on by 1 drug in DrugBank.

Gene name
blaB1
UniProtKB entry
O08498Swiss-Prot
Cellular location
Cytoplasmic
Residues / weight
249 residues · 28,144 Da
Also known as
3.5.2.6 · B2 metallo-beta-lactamase · Beta-lactamase type II · blaB · Carbapenem-hydrolyzing beta-lactamase BlaB-1

Resolves to

Structure
Drugs

What you can answer from here — as of May 03, 2025

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
4GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Metallo-beta-lactamase type 2, and which indications are they being tested in?

Create a free account or log in to explore the full data card.

Create Account